Research

Hormonal

Once-daily oral semaglutide (up to 14 mg) reduces systolic blood pressure and total cholesterol in patients with type 2 diabetes.

If you have Type 2 Diabetes, adding oral semaglutide to your current regimen can help lower your systolic blood pressure and total cholesterol. The standard protocol starts at a low dose (3 mg) and increases to 14 mg daily over two months to minimize side effects. This oral option offers cardiovascular protection similar to the injectable version, which may be easier for you to stick with long-term.

GoodSupportsHIGH confidence
All five studies reported a consistent trend in the reduction in SBP (ranging from −2.60 to −12.74 mmHg) after oral semaglutide treatment... Lipid profile results show the most consistent trend in total cholesterol reduction (−8.80 to −22.19 mg/dL).
Stanislaus Ivanovich Krishnanda et al. · Journal of Clinical Medicine · 2025

Why this rating

Based on a systematic review of 5 clinical studies (2 RCTs, 3 prospective observational), though heterogeneity in study designs and lack of uniform baseline treatments are noted limitations.

Source

The Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients with Type 2 Diabetes: A Systematic Review

Stanislaus Ivanovich Krishnanda et al. · Journal of Clinical Medicine · 2025

DOI 10.3390/jcm14072239

systematic_review · n=5132Cited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →